BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 71993)

  • 1. Electrophoretic mobility (EM)-test for childhood cancer diagnosis.
    Nitzschke U; Zwergel T; Lampert F
    Eur J Pediatr; 1977 Oct; 126(3):163-73. PubMed ID: 71993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte sensitization in childhood solid tumours and lymphoblastic leukaemia, measured by electrophoretic mobility test.
    Lampert F; Nitzschke U; Zwergel T
    Br J Cancer; 1977 Jun; 35(6):844-9. PubMed ID: 68784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with the electrophoretic mobility test in children. A diagnostic help in pediatric oncology? (author's transl)].
    Ritter J; Oehme J
    Monatsschr Kinderheilkd (1902); 1978 Sep; 126(9):556-60. PubMed ID: 80743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
    Cerni CH; Micksche M
    Acta Neuropathol Suppl; 1975; Suppl 6():65-8. PubMed ID: 50710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
    Tautz C; Schneider W; Laier E; Brügmann G
    Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence that electrophoretic-mobility (EM) test is of no value for the diagnosis of cancer in children (author's transl)].
    Lasson U; Scherer G; Müller-Ruchholtz W
    Monatsschr Kinderheilkd; 1981 Mar; 129(3):164-7. PubMed ID: 6112683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immune diagnosis of malignant diseases. X. Value of the electrophoresis mobility test in the diagnosis of broncho-pulmonary diseases].
    Douwes FR
    Onkologie; 1978 Apr; 1(2):79-84. PubMed ID: 82241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements of the electrophoretic mobility test to measure lymphocyte sensitization.
    Zwergel T; Nitzschke U; Franke F; Lampert F
    Microsc Acta; 1978 Jul; 80(5):383-90. PubMed ID: 692441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
    Hoffmann W; Werner W; Steiner R; Kaufmann R
    Br J Cancer; 1981 May; 43(5):588-97. PubMed ID: 6166306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunodiagnostics of malignant disease. VI. Electrophoretic mobility test (EMT) in malignant melanoma.
    Douwes FR; Spellmann HJ; Mross K; Wolfrum DI
    Oncology; 1978; 35(4):163-7. PubMed ID: 81476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The electrophoretic mobility test with myelin basic protein, binding of 125I-MBP to lymphocytes, and gel electrophoresis pattern of supernatant during incubation.
    Mross K; Mross B; Wolfrum DI; Kohlschütter A
    Res Exp Med (Berl); 1980; 177(3):245-53. PubMed ID: 6160602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problems of early diagnosis of neoplasms in children].
    Plenert W
    Z Arztl Fortbild (Jena); 1979 Jul; 73(13-14):665-6. PubMed ID: 228504
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A contribution to immunological tumour diagnostics in urology.
    Günther M; Friedrich A; Erdmann T; Jenssen HL; Werner H; Seyfarth M; Köhler H
    Int Urol Nephrol; 1978; 10(2):111-5. PubMed ID: 81191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroblue tetrazolium (NBT) test in children with acute lymphoblastic leukemia or malignant lymphomas.
    Zajaczkowski J; Kolanowska H; Pituch A
    Med Interne; 1976; 14(2):121-3. PubMed ID: 1071476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
    Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
    Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.